跳转至内容
Merck
  • [Allopurinol hypersensitivity syndrome: Liver transplantation after treatment of asymptomatic hyperuricaemia].

[Allopurinol hypersensitivity syndrome: Liver transplantation after treatment of asymptomatic hyperuricaemia].

Deutsche medizinische Wochenschrift (1946) (2014-11-26)
S E Miederer, K O Miederer
摘要

A 41 year old patient started treatment with 300 mg/d allopurinol for asymptomatic hyperuricaemia (9,2 mg/dl). 4 weeks later he developed exfoliative skin lesions with haemorrhage, fever, eosinophilia and acute liver and renal failure, typical for an allopurinol hypersensitivity syndrome (AHS).An orthotopic liver-transplantation was performed. The AHS is a serious iatrogenic disease. 2 % of the treated patients develop a skin rash. 0,4 % of these patients experience suddenly and unforeseen a severe hypersensitivity with a mortality of 14-30 %. An early diagnosis is often very difficult. In the pathogenesis different causes are discussed. A hereditary component is involved. Of essential importance is the amount of the starting dose, the kidney function and concomitant drugs. In an asymptomatic hyperuricaemia the application of allopurinol is not indicated. If strong indications are present, the allopurinol therapy has to start with the lowest dose (100 mg/d). If required this dose should be increased under consequent supervision only.

材料
货号
品牌
产品描述

Sigma-Aldrich
阿莫西林, 95.0-102.0% anhydrous basis
Sigma-Aldrich
别嘌醇, xanthine oxidase inhibitor
USP
阿莫西林, United States Pharmacopeia (USP) Reference Standard
Supelco
阿莫西林 三水合物, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
阿莫西林 三水合物, VETRANAL®, analytical standard
Supelco
别嘌醇, Pharmaceutical Secondary Standard; Certified Reference Material
阿莫西林 三水合物, European Pharmacopoeia (EP) Reference Standard
阿莫西林 三水合物, European Pharmacopoeia (EP) Reference Standard
别嘌醇, European Pharmacopoeia (EP) Reference Standard